Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: METASTATIC RENAL CELL CARCINOMA, . Treffer: 14

2019

Mischinger, J; Fröhlich, E; Mannweiler, S; Meindl, C; Absenger-Novak, M; Hutterer, GC; Seles, M; Augustin, H; Chromecki, TF; Jesche-Chromecki, J; Pummer, K; Zigeuner, R Prognostic value of B7-H1, B7-H3 and the stage, size, grade and necrosis (SSIGN) score in metastatic clear cell renal cell carcinoma.
Cent European J Urol. 2019; 72(1): 23-31. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Seles, M; Posch, F; Pichler, GP; Gary, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M Blood Platelet Volume Represents a Novel Prognostic Factor in Patients with Nonmetastatic Renal Cell Carcinoma and Improves the Predictive Ability of Established Prognostic Scores.
J Urol. 2017; 198(6):1247-1252
Web of Science PubMed FullText FullText_MUG

 

2015

Bezan, A; Mrsic, E; Krieger, D; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma.
J Urol. 2015; 194(1):30-35
Web of Science PubMed FullText FullText_MUG

 

Dalpiaz, O; Pichler, M; Mrsic, E; Reitz, D; Krieger, D; Venturino, L; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
J Clin Pathol. 2015; 68(7):547-551
Web of Science PubMed FullText FullText_MUG

 

Hutterer, GC; Krieger, D; Mrsic, E; Pohlmann, K; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell Carcinoma.
Anticancer Res. 2015; 35(6):3463-3469
Web of Science PubMed

 

Tilki, D; Hu, B; Nguyen, HG; Dall'Era, MA; Bertini, R; Carballido, JA; Chandrasekar, T; Chromecki, T; Ciancio, G; Daneshmand, S; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Linares, E; Lorentz, CA; Mandel, P; Martinez-Salamanca, JI; Master, VA; Matloob, R; McKiernan, JM; Mlynarczyk, CM; Montorsi, F; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Ramaswamy, K; Rodriguez Faba, O; Russo, P; Shariat, SF; Spahn, M; Terrone, C; Thieu, W; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA; Evans, CP Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy.
J Urol. 2015; 193(2):436-442
Web of Science PubMed FullText FullText_MUG

 

2014

Hutterer, GC; Stoeckigt, C; Stojakovic, T; Jesche, J; Eberhard, K; Pummer, K; Zigeuner, R; Pichler, M Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma.
Urol Oncol. 2014; 32(7):1041-1048
Web of Science PubMed FullText FullText_MUG

 

2013

Brookman-May, S; Langenhuijsen, JF; Volpe, A; Minervini, A; Joniau, S; Salagierski, M; Roscigno, M; Akdogan, B; Vandromme, A; Rodriguez-Faba, O; Marszalek, M Management of localized and locally advanced renal tumors. A contemporary review of current treatment options.
Minerva Med. 2013; 104(3):237-259
Web of Science PubMed

 

2008

Cindolo, L; Chiodini, P; Gallo, C; Ficarra, V; Schips, L; Tostain, J; de La Taille, A; Artibani, W; Patard, JJ Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomy.
Cancer. 2008; 113(1):65-71 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2007

Hutterer, GC; Patard, JJ; Colombel, M; Belldegrun, AS; Pfister, C; Guille, F; Artibani, W; Montorsi, F; Pantuck, AJ; Karakiewicz, PI Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma.
Cancer. 2007; 110(11):2428-2433 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Karakiewicz, PI; Hutterer, GC Predicting cancer-control outcomes in patients with renal cell carcinoma.
Curr Opin Urol. 2007; 17(5): 295-302.
Web of Science PubMed FullText FullText_MUG

 

2005

Cindolo, L; Patard, JJ; Chiodini, P; Schips, L; Ficarra, V; Tostain, J; de La Taille, A; Altieri, V; Lobel, B; Zigeuner, RE; Artibani, W; Guillé, F; Abbou, CC; Salzano, L; Gallo, C Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
CANCER. 2005; 104: 1362-1371. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Zigeuner, R; Ratschek, M; Langner, C Kit (CD117) immunoreactivity is rare in renal cell and upper urinary tract transitional cell carcinomas.
BJU INT. 2005; 95(3): 315-318. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2002

Greinix, HT DLI or second transplant.
Ann Hematol. 2002; 81 Suppl 2(5):S34-S35
Web of Science PubMed

 

© Med Uni Graz Impressum